Benztropine: Difference between revisions
ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: Anticholinergic *Dosage Forms: *Routes of Administration: IV, IM, oral *Common Trade Names: Cogentin ==Adult Dosing== *Extrapyramidal disease: 1-4 m...") |
(edited dosage forms, strengths) |
||
Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: Anticholinergic | *Type: Anticholinergic | ||
*Dosage Forms: | *Dosage Forms: tablet, injectable solution | ||
*Dosage Strengths: tablet: 0.5, 1, 2mg; injectable solution: 1mg/mL | |||
*Routes of Administration: IV, IM, oral | *Routes of Administration: IV, IM, oral | ||
*Common Trade Names: Cogentin | *Common Trade Names: Cogentin |
Revision as of 22:42, 11 October 2017
Administration
- Type: Anticholinergic
- Dosage Forms: tablet, injectable solution
- Dosage Strengths: tablet: 0.5, 1, 2mg; injectable solution: 1mg/mL
- Routes of Administration: IV, IM, oral
- Common Trade Names: Cogentin
Adult Dosing
- Extrapyramidal disease: 1-4 mg IV/IM/PO 1-2 times daily
- Parkinsonism: 0.5 mg IM/IV/PO daily, titrate up in 0.5mg increments
Pediatric Dosing
- Contraindicated children <3 years old. Otherwise, same as adult dosing
Special Populations
- Pregnancy Rating: B
- Lactation risk: Infant risk cannot be ruled out
Renal: no adjustment Hepatic: no adjustment
Contraindications
- Allergy to class/drug
- Age <3 years
Adverse Reactions
Serious
- Psychosis, confusion, hallucinations
- Hyperpyrexia, heat stroke, anhidrosis
- Paralytic ileus
Common
- Tachycardia
- Constipation, nausea, xerostomia
- Blurry vision
- Urinary retention
Pharmacology
- Half-life: duration of action is around 24 hours
- Metabolism:
- Excretion:
Mechanism of Action
- Anticholinergic, reduces imbalance between acetylcholine and dopamine